1980
DOI: 10.2307/2530496
|View full text |Cite
|
Sign up to set email alerts
|

The Crossover Experiment for Clinical Trials

Abstract: The two-period crossover or changeover design for clinical trials is compared with other simple designs in terms of statistical precision and cost. The sensitivity of the crossover to bias due to carryover effects is examined. The feasibility of using the crossover data to test for the existence of carryover effects is investigated and found to be uneconomical. A numerical example is presented.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
120
0
5

Year Published

1987
1987
2013
2013

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 349 publications
(126 citation statements)
references
References 6 publications
1
120
0
5
Order By: Relevance
“…Data means were compared using the two-tailed Student's t-test (Brown 1980), with p < 0.05 denoting significance.…”
Section: Methodsmentioning
confidence: 99%
“…Data means were compared using the two-tailed Student's t-test (Brown 1980), with p < 0.05 denoting significance.…”
Section: Methodsmentioning
confidence: 99%
“…It is the correlation between pairs of measurements in Period 1 and 2, taken on randomly selected subjects (Brown, 1980). Brown (1980) stressed the efficiency of the simple crossover design relative to a completely randomized trial, in case the assumption of no carry-over is likely to be valid.…”
Section: The Crossover Designmentioning
confidence: 99%
“…Brown (1980) stressed the efficiency of the simple crossover design relative to a completely randomized trial, in case the assumption of no carry-over is likely to be valid. The ratio of the error variance of a crossover trial and a simple randomized trial with an equal number of subjects included in both trials, is (Brown, 1980):…”
Section: The Crossover Designmentioning
confidence: 99%
See 1 more Smart Citation
“…effect increases or decreases the effectiveness of the later treatment, is known as carryover (Brown 1980). Carryover is an important risk in medical experiments, as drug residues can remain in the body for quite some time and interact with later treatments (Senn 2002).…”
Section: Designmentioning
confidence: 99%